Andreas Plaitakis

Prof. Dr. Andreas Plaitakis

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2016 in Biochemical Journal
Verified
Journal Article
Open access
PDF file
EKEster Kalef-Ezra
Ester Kalef-Ezra
DKDimitra Kotzamani
Dimitra Kotzamani
IZIoannis Zaganas
Ioannis Zaganas
NKNitsa Katrakili
Nitsa Katrakili
APAndreas Plaitakis
Andreas Plaitakis
KTKostas Tokatlidis
Kostas Tokatlidis
Mammalian glutamate dehydrogenase (GDH), a nuclear-encoded enzyme central to cellular metabolism, is among the most abundant mitochondrial proteins (constituting up to 10% of matrix proteins). To attain such high levels, GDH depends on very efficient mitochondrial targeting that, for human isoenzymes hGDH1 and hGDH2, is mediated by an unusually long cleavable presequence (N53). Here, we studied the mitochondrial transport of these proteins using isolated yeast mitochondria and human cell lines. We found that both hGDHs were very rapidly imported and processed in isolated mitochondria, with their presequences (N53) alone being capable of directing non-mitochondrial proteins into mitochondria. These presequences were predicted to form two α helices (α1: N 1–10; α2: N 16–32) separated by loops. Selective deletion of the α1 helix abolished the mitochondrial import of hGDHs. While the α1 helix alone had a very weak hGDH mitochondrial import capacity, it could direct efficiently non-mitochondrial proteins into mitochondria. In contrast, the α2 helix had no autonomous mitochondrial-targeting capacity. A peptide consisting of α1 and α2 helices without intervening sequences had GDH transport efficiency comparable with that of N53. Mutagenesis of the cleavage site blocked the intra-mitochondrial processing of hGDHs, but did not affect their mitochondrial import. Replacement of all three positively charged N-terminal residues (Arg3, Lys7 and Arg13) by Ala abolished import. We conclude that the synergistic interaction of helices α1 and α2 is crucial for the highly efficient import of hGDHs into mitochondria.

18 May 2018 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
APAndreas Plaitakis
Andreas Plaitakis
DKDimitra Kotzamani
Dimitra Kotzamani
ZPZoe Petraki
Zoe Petraki
MDMaria Delidaki
Maria Delidaki
VRVagelis Rinotas
Vagelis Rinotas
CSCleanthe Spanaki
Cleanthe Spanaki

26 January 2015 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
VMVasileios Mastorodemos
Vasileios Mastorodemos
KKKonstantinos Kanavouras
Konstantinos Kanavouras
SSShobana Sundaram
Shobana Sundaram
MPMaria Providaki
Maria Providaki
ZPZoe Petraki
Zoe Petraki
APAndreas Plaitakis
Andreas Plaitakis

21 January 2024 in iScience
Verified
Journal Article
Open access
CSCleanthe Spanaki
Cleanthe Spanaki
KSKyriaki Sidiropoulou
Kyriaki Sidiropoulou
ZPZoe Petraki
Zoe Petraki
KDKonstantinos Diskos
Konstantinos Diskos
XKXanthippi Konstantoudaki
Xanthippi Konstantoudaki
APAndreas Plaitakis
Andreas Plaitakis
The human brain is characterized by the upregulation of synaptic, mainly glutamatergic, transmission, but its evolutionary origin(s) remain elusive. Here we approached this fundamental question by studying mice transgenic (Tg) for GLUD2, a human gene involved in glutamate metabolism that emerged in the hominoid and evolved concomitantly with brain expansion. We demonstrate that Tg mice express the human enzyme in hippocampal astrocytes and CA1-CA3 pyramidal neurons. LTP, evoked by theta-burst stimulation, is markedly enhanced in the CA3-CA1 synapses of Tg mice, with patch-clamp recordings from CA1 pyramidal neurons revealing increased sNMDA currents. LTP enhancement is blocked by D-lactate, implying that GLUD2 potentiates L-lactate-mediated astrocyte-neuron interaction. Dendritic spine density and synaptogenesis are increased in the hippocampus of Tg mice, which exhibit enhanced responses to sensory stimuli and improved performance on complex memory tasks. Hence, GLUD2 likely contributed to human brain evolution by enhancing synaptic plasticity and metabolic processes central to cognitive functions.

Verified
Journal Article
Open access
PDF file
APAndreas Plaitakis
Andreas Plaitakis
KSKyriaki Sidiropoulou
Kyriaki Sidiropoulou
DKDimitra Kotzamani
Dimitra Kotzamani
ILIonela Litso
Ionela Litso
IZIoannis Zaganas
Ioannis Zaganas
CSCleanthe Spanaki
Cleanthe Spanaki
Human evolution is characterized by rapid brain enlargement and the emergence of unique cognitive abilities. Besides its distinctive cytoarchitectural organization and extensive inter-neuronal connectivity, the human brain is also defined by high rates of synaptic, mainly glutamatergic, transmission, and energy utilization. While these adaptations’ origins remain elusive, evolutionary changes occurred in synaptic glutamate metabolism in the common ancestor of humans and apes via the emergence of GLUD2, a gene encoding the human glutamate dehydrogenase 2 (hGDH2) isoenzyme. Driven by positive selection, hGDH2 became adapted to function upon intense excitatory firing, a process central to the long-term strengthening of synaptic connections. It also gained expression in brain astrocytes and cortical pyramidal neurons, including the CA1-CA3 hippocampal cells, neurons crucial to cognition. In mice transgenic for GLUD2, theta-burst-evoked long-term potentiation (LTP) is markedly enhanced in hippocampal CA3-CA1 synapses, with patch-clamp recordings from CA1 pyramidal neurons revealing increased sNMDA receptor currents. D-lactate blocked LTP enhancement, implying that glutamate metabolism via hGDH2 potentiates L-lactate-dependent glia–neuron interaction, a process essential to memory consolidation. The transgenic (Tg) mice exhibited increased dendritic spine density/synaptogenesis in the hippocampus and improved complex cognitive functions. Hence, enhancement of neuron–glia communication, via GLUD2 evolution, likely contributed to human cognitive advancement by potentiating synaptic plasticity and inter-neuronal connectivity.

9 September 2022 in Neurology Genetics
Verified
Journal Article
Open access
PDF file
MTMinas Tzagournissakis
Minas Tzagournissakis
EFEMMANOUIL FOUKARAKIS
EMMANOUIL FOUKARAKIS
DSDimitrios Samonakis
Dimitrios Samonakis
MTMiltiadis Tsilimbaris
Miltiadis Tsilimbaris
KMKleita Michaelidou
Kleita Michaelidou
IZIoannis Zaganas
Ioannis Zaganas
Background and Objectives Our goal was to study hereditary transthyretin-related amyloidosis (hATTR) in Crete, Greece. Methods We aimed at ascertaining all hATTR cases in Crete, an island of 0.62 million people. For this, we evaluated patients with polyneuropathy, autonomic involvement, cardiomyopathy, and/or ophthalmopathy suggestive of hATTR, who presented to the physicians of this study or were referred to them by other physicians. Genetic analyses were performed on all patients suspected of suffering from hATTR. We included in our observational longitudinal cohort study all individuals, residents of Crete, who, during the study period (1993–2019), were found to carry a pathogenic TTR variant. Results Over the past 27 years, 30 individuals (15 female patients, 15 male patients), from 12 apparently unrelated families, were diagnosed with hATTR, whereas evaluation of their offspring identified 5 asymptomatic TTR pathogenic variant carriers. The most prevalent TTR variant detected was p.Val50Met, affecting 19 patients (11 female patients, 8 male patients) and causing a rather consistent phenotype characterized by predominant polyneuropathy of early adult onset (median age of symptom onset: 30 years; range: 18–37 years). Specifically, patients affected by the p.Val50Met TTR variant experienced progressive sensorimotor disturbances, involving mainly the lower extremities, associated with autonomic and/or gastrointestinal dysfunction. The second most frequent TTR variant was p.Val114Ala, found in 10 patients (4 female patients, 6 male patients) who were affected at an older age (median age of symptom onset: 70 years; range: 54–78 years). This variant caused a predominantly cardiomyopathic phenotype, manifested by congestive heart failure and associated with peripheral neuropathy, carpal tunnel syndrome, and/or autonomic involvement. In these patients, cardiac amyloid deposition was detected on 99m-technetium pyrophosphate scintigraphy and/or heart biopsy. The third TTR variant (p.Arg54Gly) was found in a 50-year-old male patient with ophthalmopathy due to vitreous opacities and positive family history for visual loss. As 22 patients were alive at the end of the study, we calculated the hATTR prevalence in Crete to be 35 cases per 1 million inhabitants. Discussion Our study revealed that the prevalence of hATTR in Crete is one of the world9s highest. Three different pathogenic TTR variants causing distinct clinical phenotypes were identified in this relatively small population pool.